SGRY Stock Analysis: Buy, Sell, or Hold?
SGRY - Surgery Partners, Inc. Common Stock
$13.95
-0.57 (-3.93%)
▼
5d:
-2.86%
30d:
-11.32%
90d:
+4.1%
HOLD
MODERATE Confidence
Analysis Updated: Aug 24, 2026 12:00 AM ET
Earnings: Aug 10, 2026
0d
Get Alerted When SGRY Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: SGRY shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: SGRY shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$30.08
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$18.68
25.3% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: SGRY is currently trading at $13.95, which is considered oversold relative to its 30-day fair value range of $14.52 to $16.05. From a valuation perspective, the stock is trading at a discount (Forward PE: 22.6) compared to its historical average (25.1). Remarkably, the market is currently pricing in an annual earnings decline of 3.5% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, SGRY is in a uptrend. Immediate support is located at $13.52, while resistance sits at $16.28. Short-term momentum is weak, with the stock down 3.9% recently.
Market Sentiment: The stock scores a mixed 58/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $18.73 (+34.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, SGRY is in a uptrend. Immediate support is located at $13.52, while resistance sits at $16.28. Short-term momentum is weak, with the stock down 3.9% recently.
Market Sentiment: The stock scores a mixed 58/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $18.73 (+34.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$14.52 -
$16.05
Company Quality Score
55/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
74.8%
Protect Your Profits
Holding SGRY? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (58/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-3.9%)
- BULLISH: Trading 34.2% below Wall St target ($18.73)
- NEUTRAL: Bottoming setup forming (58/100) — watch for confirmation
Trading Range Analysis
30-Day Trading Range
$14.52 -
$16.05
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$13.52
Resistance Level
$16.28
Current Trend
Uptrend
Technical data as of
Aug 24, 2026
Fundamental Context
Forward P/E (Next Year Est.)
22.58
Wall Street Target
$18.73
(+34.2%)
Revenue Growth (YoY)
2.7%
Profit Margin
-2.6%
Valuation Discount vs History
-3.5% cheaper
PE vs Historical
22.6 vs 25.1
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-3.5%
(market-implied from PE analysis)
1-Year Target
$13.46
(-4%)
2-Year Target
$12.99
(-7%)
3-Year Target
$12.54
(-10%)
3-Yr Target (if PE normalizes)
(PE: 23→25)
$13.93
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.6, Growth: 27.4%)
$28.87
(+107%)
Base:
(SPY PE: 20.1, Growth: 27.4%)
$25.63
(+84%)
Bear:
(PE: 17.0, Growth: 27.4%)
$21.79
(+56%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 22.6 to 25.1
Stabilization Target:
$15.51
(+11.2%)
PE Expansion Potential:
+11.2%
Share & Embed Analysis
Last updated: August 24, 2026 7:43 PM ET
Data refreshes hourly during market hours. Next update: 8:43 PM
Data refreshes hourly during market hours. Next update: 8:43 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SGRY showing a specific setup today?
Insider Activity (6 Months)
0
Buys
12
Sells
Net
INSIDERS SELLING
Recent Transactions
David T Doherty
SELL
8867 shares
2026-03-16
Jason Eric Evans
SELL
20400 shares
2026-03-16
Danielle Burkhalter
SELL
3469 shares
2026-03-13
Top Rated Medical Care Facilities Stocks
Top-rated stocks in Medical Care Facilities by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
THC
Tenet Healthcare Corpora… |
STRONG BUY
22 analysts |
$282 | 34 SELL |
|
HCA
HCA Healthcare, Inc. |
BUY
25 analysts |
$451 | 43 HOLD |
|
EHC
Encompass Health Corp |
STRONG BUY
12 analysts |
$148 | 41 HOLD |
|
CMPS
Compass Pathways Plc |
STRONG BUY
11 analysts |
$24 | 40 SELL |
|
ADUS
Addus HomeCare Corporati… |
STRONG BUY
11 analysts |
$135 | 48 HOLD |
Advanced SGRY Option Strategies
Professional options setups generated by AI based on today's SGRY price and gamma walls.
